Molecular and spatial analysis of tertiary lymphoid structures in Sjogren’s syndrome
2024

Mapping Tertiary Lymphoid Structures in Sjogren’s Syndrome

Sample size: 7 publication 10 minutes Evidence: high

Author Information

Author(s): Saba Nayar, Jason D. Turner, Saba Asam, Eanna Fennell, Matthew Pugh, Serena Colafrancesco, Onorina Berardicurti, Charlotte G. Smith, Joe Flint, Ana Teodosio, Valentina Iannizzotto, David H. Gardner, Joel van Roon, Ilya Korsunsky, Dawn Howdle, Michael Brenner, Mark Coles, Fiona M. Powrie, Soumya Raychaudhuri, Andreas P. Frei, Kara G. Lassen, Simon J. Bowman, Wan-Fai Ng, Adam P. Croft, Andrew Filer, Benjamin A. Fisher, Christopher D. Buckley, Francesca Barone

Primary Institution: University of Birmingham, Birmingham, UK

Hypothesis

What are the cellular and molecular properties involved in the formation and function of tertiary lymphoid structures in Sjogren’s syndrome?

Conclusion

The study provides a comprehensive cellular and spatial map of tertiary lymphoid structures in Sjogren’s syndrome, identifying key cellular players and their interactions.

Supporting Evidence

  • Tertiary lymphoid structures are important in autoimmune diseases and cancer.
  • Single-cell RNA sequencing revealed diverse cellular populations in salivary glands.
  • Fibroblasts play a crucial role in the formation and maintenance of tertiary lymphoid structures.
  • Distinct cellular interactions were identified that may influence immune responses.
  • Comparative analysis between Sjogren’s syndrome and Sicca syndrome highlighted key differences in immune cell profiles.

Takeaway

Researchers looked at tiny structures in the salivary glands of people with Sjogren’s syndrome to understand how they help the immune system work, which could lead to new treatments.

Methodology

The study used single-cell RNA sequencing, spatial transcriptomics, and proteomics on salivary gland biopsies from patients.

Potential Biases

Potential biases may arise from the selection of patient samples and the methodologies used for analysis.

Limitations

The study is limited to a small sample size and specific patient demographics, which may not represent the broader population.

Participant Demographics

Patients with Sjogren’s syndrome, specific demographics not detailed.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41467-024-54686-0

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication